US25386A
(en)
|
|
1859-09-13 |
|
Fastening fob |
US2833779A
(en)
|
1956-10-29 |
1958-05-06 |
American Cyanamid Co |
Substituted pyrazoles
|
US2918408A
(en)
|
1957-04-08 |
1959-12-22 |
Lakeside Lab Inc |
Anti-spasmodic compositions specific for treating spasm of the colon
|
US3631045A
(en)
|
1969-11-04 |
1971-12-28 |
American Home Prod |
4 5-diamino-7h-pyrrolo(2 3-d)pyrimidine derivatives
|
US3910913A
(en)
|
1969-11-04 |
1975-10-07 |
American Home Prod |
4,5-Diamino-7H-pyrrolo{8 2,3-d{9 pyrimidine derivatives
|
US3707475A
(en)
|
1970-11-16 |
1972-12-26 |
Pfizer |
Antiinflammatory imidazoles
|
US3940486A
(en)
|
1971-05-10 |
1976-02-24 |
Ciba-Geigy Corporation |
Imidazole derivatives in the treatment of pain
|
US3929807A
(en)
|
1971-05-10 |
1975-12-30 |
Ciba Geigy Corp |
2-Substituted-4(5)-(aryl)-5(4)-(2,3 or -4-pyridyl)-imidazoles
|
CA966134A
(en)
|
1972-05-05 |
1975-04-15 |
Haydn W.R. Williams |
1,8-naphthyridine compounds
|
US4058614A
(en)
|
1973-12-04 |
1977-11-15 |
Merck & Co., Inc. |
Substituted imidazole compounds and therapeutic compositions therewith
|
US4199592A
(en)
|
1978-08-29 |
1980-04-22 |
E. I. Du Pont De Nemours And Company |
Antiinflammatory 4,5-diaryl-2-nitroimidazoles
|
ZA803539B
(en)
*
|
1979-06-14 |
1982-01-27 |
Wellcome Found |
Alkoxybenzylrimidines method for their preparation formulation thereof and their use in medicine
|
CY1308A
(en)
|
1979-12-06 |
1985-12-06 |
Glaxo Group Ltd |
Device for dispensing medicaments
|
DD201677A5
(de)
|
1980-07-25 |
1983-08-03 |
Ciba Geigy |
Verfahren zur herstellung von trisubstituierten imidazolderivaten
|
US4353656A
(en)
|
1980-10-14 |
1982-10-12 |
Xerox Corporation |
Moving coil, multiple energy print hammer system including a closed loop servo
|
CY1492A
(en)
|
1981-07-08 |
1990-02-16 |
Draco Ab |
Powder inhalator
|
WO1983002613A1
(en)
|
1981-07-20 |
1983-08-04 |
Sallmann, Alfred |
Trisubstituted oxazo compounds
|
US4503065A
(en)
|
1982-08-03 |
1985-03-05 |
E. I. Du Pont De Nemours And Company |
Antiinflammatory 4,5-diaryl 1-2-halo imidazoles
|
US4778054A
(en)
|
1982-10-08 |
1988-10-18 |
Glaxo Group Limited |
Pack for administering medicaments to patients
|
GB2169265B
(en)
|
1982-10-08 |
1987-08-12 |
Glaxo Group Ltd |
Pack for medicament
|
AU570013B2
(en)
|
1982-10-08 |
1988-03-03 |
Glaxo Group Limited |
Medicament inhaler
|
JPS60226882A
(ja)
|
1984-04-24 |
1985-11-12 |
Nippon Zoki Pharmaceut Co Ltd |
新規ピリミドピリミジン誘導体
|
US4565875A
(en)
|
1984-06-27 |
1986-01-21 |
Fmc Corporation |
Imidazole plant growth regulators
|
US4560691A
(en)
|
1984-07-13 |
1985-12-24 |
Sterling Drug Inc. |
5-(Phenyl)-1,6-naphthyridin-2(1H)-ones, their cardiotonic use and preparation
|
CA1272917A
(en)
|
1985-07-30 |
1990-08-21 |
Paul Kenneth Rand |
Devices for administering medicaments to patients
|
US4686231A
(en)
|
1985-12-12 |
1987-08-11 |
Smithkline Beckman Corporation |
Inhibition of 5-lipoxygenase products
|
IL83467A0
(en)
|
1986-08-15 |
1988-01-31 |
Fujisawa Pharmaceutical Co |
Imidazole derivatives,processes for their preparation and pharmaceutical compositions containing the same
|
AU598093B2
(en)
|
1987-02-07 |
1990-06-14 |
Wellcome Foundation Limited, The |
Pyridopyrimidines, methods for their preparation and pharmaceutical formulations thereof
|
JPH01261306A
(ja)
|
1988-04-13 |
1989-10-18 |
Nippon Kayaku Co Ltd |
2−アルキルチオ−4−アミノピリミジン誘導体を有効成分とする開花促進剤
|
GB9004781D0
(en)
|
1990-03-02 |
1990-04-25 |
Glaxo Group Ltd |
Device
|
BG94957A
(bg)
|
1990-08-10 |
1993-12-24 |
Ciba - Geigy Ag |
Пиримидинови производни и средство за борба срещу вредители по растенията
|
FR2665898B1
(fr)
|
1990-08-20 |
1994-03-11 |
Sanofi |
Derives d'amido-3 pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
|
IE913473A1
(en)
|
1990-10-15 |
1992-04-22 |
Fujisawa Pharmaceutical Co |
Quinazoline derivatives and their preparation
|
WO1992012154A1
(en)
|
1990-12-31 |
1992-07-23 |
Fujisawa Pharmaceutical Co., Ltd. |
Imidazotriazine derivatives
|
JP3375659B2
(ja)
|
1991-03-28 |
2003-02-10 |
テキサス インスツルメンツ インコーポレイテツド |
静電放電保護回路の形成方法
|
SG64322A1
(en)
*
|
1991-05-10 |
1999-04-27 |
Rhone Poulenc Rorer Int |
Bis mono and bicyclic aryl and heteroaryl compounds which inhibit egf and/or pdgf receptor tyrosine kinase
|
FR2676734B1
(fr)
|
1991-05-23 |
1995-05-19 |
Roussel Uclaf |
Nouveaux derives de la pyrimidine, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant.
|
IL102764A0
(en)
|
1991-08-16 |
1993-01-31 |
Merck & Co Inc |
Quinazoline derivatives,and pharmaceutical compositions containing them
|
DE4131029A1
(de)
*
|
1991-09-18 |
1993-07-29 |
Basf Ag |
Substituierte pyrido (2,3-d) pyrimidine als antidots
|
GB9127376D0
(en)
|
1991-12-24 |
1992-02-19 |
Wellcome Found |
Amidino derivatives
|
US6008235A
(en)
|
1992-01-13 |
1999-12-28 |
Smithkline Beecham Corporation |
Pyridyl substituted imidazoles
|
IL104369A0
(en)
|
1992-01-13 |
1993-05-13 |
Smithkline Beecham Corp |
Novel compounds and compositions
|
US5656644A
(en)
|
1994-07-20 |
1997-08-12 |
Smithkline Beecham Corporation |
Pyridyl imidazoles
|
US5916891A
(en)
|
1992-01-13 |
1999-06-29 |
Smithkline Beecham Corporation |
Pyrimidinyl imidazoles
|
US5716972A
(en)
|
1993-01-13 |
1998-02-10 |
Smithkline Beecham Corporation |
Pyridyl substituted imidazoles
|
HU225869B1
(en)
|
1992-04-02 |
2007-11-28 |
Smithkline Beecham Corp |
Compounds with antiallergic and antiinflammatory activity and pharmaceutical compns. contg. them
|
GB9303993D0
(en)
|
1993-02-26 |
1993-04-14 |
Fujisawa Pharmaceutical Co |
New heterocyclic derivatives
|
US5466692A
(en)
|
1993-03-24 |
1995-11-14 |
American Home Products Corporation |
Substituted pyridopyrimidines and antihypertensives
|
US5670527A
(en)
|
1993-07-16 |
1997-09-23 |
Smithkline Beecham Corporation |
Pyridyl imidazole compounds and compositions
|
US5593991A
(en)
|
1993-07-16 |
1997-01-14 |
Adams; Jerry L. |
Imidazole compounds, use and process of making
|
US5593992A
(en)
|
1993-07-16 |
1997-01-14 |
Smithkline Beecham Corporation |
Compounds
|
NZ274063A
(en)
|
1993-09-17 |
1997-11-24 |
Smithkline Beecham Corp |
Cytokine suppressive anti-inflammatory drug binding protein (csbp) and its use
|
US5783664A
(en)
|
1993-09-17 |
1998-07-21 |
Smithkline Beecham Corporation |
Cytokine suppressive anit-inflammatory drug binding proteins
|
US5869043A
(en)
|
1993-09-17 |
1999-02-09 |
Smithkline Beecham Corporation |
Drug binding protein
|
US5426110A
(en)
|
1993-10-06 |
1995-06-20 |
Eli Lilly And Company |
Pyrimidinyl-glutamic acid derivatives
|
EP1306377A3
(en)
|
1993-11-08 |
2003-05-07 |
Smithkline Beecham Corporation |
Pyridyl-oxazoles and their use as cytokines inhibitors
|
GB9325217D0
(en)
|
1993-12-09 |
1994-02-09 |
Zeneca Ltd |
Pyrimidine derivatives
|
IL112249A
(en)
|
1994-01-25 |
2001-11-25 |
Warner Lambert Co |
Pharmaceutical compositions containing di and tricyclic pyrimidine derivatives for inhibiting tyrosine kinases of the epidermal growth factor receptor family and some new such compounds
|
US5559137A
(en)
|
1994-05-16 |
1996-09-24 |
Smithkline Beecham Corp. |
Compounds
|
US5547954A
(en)
*
|
1994-05-26 |
1996-08-20 |
Fmc Corporation |
2,4-Diamino-5,6-disubstituted-and 5,6,7-trisubstituted-5-deazapteridines as insecticides
|
US5545669A
(en)
|
1994-06-02 |
1996-08-13 |
Adams; Jerry L. |
Anti-inflammatory compounds
|
TW574214B
(en)
|
1994-06-08 |
2004-02-01 |
Pfizer |
Corticotropin releasing factor antagonists
|
EP0765308B1
(en)
|
1994-06-15 |
2000-04-05 |
The Wellcome Foundation Limited |
Enzyme inhibitors
|
US5998428A
(en)
|
1995-05-31 |
1999-12-07 |
Smithkline Beecham Corporation |
Compounds and methods for treating PDE IV-related diseases
|
NZ291507A
(en)
*
|
1994-08-29 |
1997-12-19 |
Yamanouchi Pharma Co Ltd |
1,8-naphthyridine derivatives; medicaments
|
IL115256A0
(en)
|
1994-11-14 |
1995-12-31 |
Warner Lambert Co |
6-Aryl pyrido (2,3-d) pyrimidines and naphthyridines and their use
|
AU698364B2
(en)
|
1995-03-10 |
1998-10-29 |
Minnesota Mining And Manufacturing Company |
Aerosol valves
|
US5620981A
(en)
|
1995-05-03 |
1997-04-15 |
Warner-Lambert Company |
Pyrido [2,3-D]pyrimidines for inhibiting protein tyrosine kinase mediated cellular proliferation
|
US5739143A
(en)
|
1995-06-07 |
1998-04-14 |
Smithkline Beecham Corporation |
Imidazole compounds and compositions
|
US5658903A
(en)
|
1995-06-07 |
1997-08-19 |
Smithkline Beecham Corporation |
Imidazole compounds, compositions and use
|
US5760220A
(en)
*
|
1995-06-07 |
1998-06-02 |
American Home Products Corporation |
Process for preparation of biphenyl derivatives
|
HUP9900871A3
(en)
|
1995-06-07 |
2000-07-28 |
Wyeth Corp |
Process for preparation of biphenyl derivatives
|
ZA9610687B
(en)
|
1995-12-22 |
1997-09-29 |
Smithkline Beecham Corp |
Novel synthesis.
|
PL187516B1
(pl)
|
1996-01-11 |
2004-07-30 |
Smithkline Beecham Corp |
Nowe podstawione pochodne imidazolu, sposób ich wytwarzania oraz kompozycja farmaceutyczna zawierająca te związki
|
ZA97175B
(en)
|
1996-01-11 |
1997-11-04 |
Smithkline Beecham Corp |
Novel substituted imidazole compounds.
|
US5767097A
(en)
*
|
1996-01-23 |
1998-06-16 |
Icn Pharmaceuticals, Inc. |
Specific modulation of Th1/Th2 cytokine expression by ribavirin in activated T-lymphocytes
|
US6150337A
(en)
|
1996-01-23 |
2000-11-21 |
Icn Pharmaceuticals, Inc. |
Specific modulation of Th1/Th2 cytokine expression by Ribavirin in activated T-lymphocytes
|
US20020137696A1
(en)
|
1996-01-23 |
2002-09-26 |
Robert Tam |
Specific modulation of TH1/TH2 cytokine expression by ribavirin in activated T-lymphocytes
|
JP2000507224A
(ja)
|
1996-03-08 |
2000-06-13 |
スミスクライン・ビーチャム・コーポレイション |
Csaid化合物の血管形成の抑制物質としての使用
|
JP2000507545A
(ja)
|
1996-03-25 |
2000-06-20 |
スミスクライン・ビーチャム・コーポレイション |
Cns損傷についての新規な治療
|
US6096739A
(en)
|
1996-03-25 |
2000-08-01 |
Smithkline Beecham Corporation |
Treatment for CNS injuries
|
CA2250943A1
(en)
|
1996-04-12 |
1997-10-23 |
Sumitomo Pharmaceuticals Company, Limited |
Piperidinylpyrimidine derivatives
|
ZA973884B
(en)
|
1996-05-23 |
1998-11-06 |
Du Pont Merck Pharma |
Tetrahydropteridines and pyridylpiperazines for treatment of neurological disorders
|
US6875769B2
(en)
|
1996-05-23 |
2005-04-05 |
Pfizer Inc. |
Substituted6,6-hetero-bicyclicderivatives
|
TR199900228T2
(xx)
|
1996-08-06 |
1999-03-22 |
Pfizer Inc. |
�kameli/katk�l� pirido-veya pirimido-i�eren 6,6-veya 6,7-bisiklik t�revler.
|
TW477787B
(en)
|
1996-08-27 |
2002-03-01 |
Pfizer |
Pyrido six-membered nitrogen-containing cyclic ring derivatives having corticotropin releasing factor antagonist activity and pharmaceutical composition containing same
|
BR9714349A
(pt)
|
1996-10-16 |
2000-11-14 |
Icn Pharmaceuticals |
L-nucleosìdeos purina, seus análogos e utilizacões dos mesmos
|
US6455690B1
(en)
|
1996-10-16 |
2002-09-24 |
Robert Tam |
L-8-oxo-7-propyl-7,8-dihydro-(9H)-guanosine
|
US6509320B1
(en)
|
1996-10-16 |
2003-01-21 |
Icn Pharmaceuticals, Inc. |
Purine L-nucleosides, analogs and uses thereof
|
US6147080A
(en)
|
1996-12-18 |
2000-11-14 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of p38
|
GB9700226D0
(en)
|
1997-01-08 |
1997-02-26 |
Glaxo Group Ltd |
Inhalation device
|
US5929076A
(en)
|
1997-01-10 |
1999-07-27 |
Smithkline Beecham Corporation |
Cycloalkyl substituted imidazoles
|
MY117948A
(en)
|
1997-01-13 |
2004-08-30 |
Glaxo Group Ltd |
Nitride oxide synthase inhibitors.
|
US6268310B1
(en)
|
1997-01-28 |
2001-07-31 |
Nippon Soda Co., Ltd. |
Oxazole derivative, process for producing the same, and herbicide
|
US6498163B1
(en)
*
|
1997-02-05 |
2002-12-24 |
Warner-Lambert Company |
Pyrido[2,3-D]pyrimidines and 4-aminopyrimidines as inhibitors of cellular proliferation
|
US5945422A
(en)
*
|
1997-02-05 |
1999-08-31 |
Warner-Lambert Company |
N-oxides of amino containing pyrido 2,3-D! pyrimidines
|
JP2001509805A
(ja)
|
1997-02-05 |
2001-07-24 |
ワーナー−ランバート・コンパニー |
細胞増殖阻害剤としてのピリド〔2,3−d〕ピリミジンおよび4−アミノピリミジン
|
DE19723722A1
(de)
|
1997-05-30 |
1998-12-10 |
Schering Ag |
Nichtsteroidale Gestagene
|
AU9281298A
(en)
|
1997-10-01 |
1999-04-23 |
Kyowa Hakko Kogyo Co. Ltd. |
Benzodioxole derivatives
|
US6362193B1
(en)
|
1997-10-08 |
2002-03-26 |
Smithkline Beecham Corporation |
Cycloalkenyl substituted compounds
|
AR017219A1
(es)
|
1997-12-19 |
2001-08-22 |
Smithkline Beecham Corp |
Derivados de imidazol 1,4,5 sustituidos, composiciones que los comprenden, procedimiento para la preparacion de dichos derivados, uso de los derivados parala manufactura de un medicamento
|
US6423695B1
(en)
|
1998-01-13 |
2002-07-23 |
Ribapharm, Inc. |
Cytokine related treatments of disease
|
US6506766B1
(en)
|
1998-02-13 |
2003-01-14 |
Abbott Laboratories |
Glucocortiocoid-selective antinflammatory agents
|
WO1999041253A1
(en)
|
1998-02-17 |
1999-08-19 |
Tularik Inc. |
Anti-viral pyrimidine derivatives
|
US6306866B1
(en)
|
1998-03-06 |
2001-10-23 |
American Cyanamid Company |
Use of aryl-substituted pyrimidines as insecticidal and acaricidal agents
|
DE69918422T2
(de)
|
1998-03-14 |
2005-08-11 |
Altana Pharma Ag |
Phthalazinone als PDE3/4 Inhibitoren
|
JP2000038350A
(ja)
|
1998-05-18 |
2000-02-08 |
Yoshitomi Pharmaceut Ind Ltd |
糖尿病治療薬
|
US6423425B1
(en)
|
1998-05-26 |
2002-07-23 |
Ppg Industries Ohio, Inc. |
Article having a chip-resistant electrodeposited coating and a process for forming an electrodeposited coating
|
BR9911590A
(pt)
|
1998-05-26 |
2001-02-13 |
Warner Lambert Co |
Pirimidinas bicìclicas e 3,4-diidropirimidinas bicìclicas como inibidores da proliferação celular
|
US20040044012A1
(en)
|
1998-05-26 |
2004-03-04 |
Dobrusin Ellen Myra |
Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidines as inhibitors of cellular proliferation
|
US6248225B1
(en)
|
1998-05-26 |
2001-06-19 |
Ppg Industries Ohio, Inc. |
Process for forming a two-coat electrodeposited composite coating the composite coating and chip resistant electrodeposited coating composition
|
GB9811599D0
(en)
|
1998-05-30 |
1998-07-29 |
Glaxo Group Ltd |
Nitric oxide synthase inhibitors
|
WO1999064400A1
(en)
|
1998-06-12 |
1999-12-16 |
Vertex Pharmaceuticals Incorporated |
INHIBITORS OF p38
|
US5907465A
(en)
|
1998-08-13 |
1999-05-25 |
Sensormatic Electronics Corporation |
Circuit for energizing EAS marker deactivation device with DC pulses of alternating polarity
|
US6184226B1
(en)
*
|
1998-08-28 |
2001-02-06 |
Scios Inc. |
Quinazoline derivatives as inhibitors of P-38 α
|
JP2002526482A
(ja)
|
1998-09-18 |
2002-08-20 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
p38のインヒビター
|
IL142257A0
(en)
*
|
1998-10-01 |
2002-03-10 |
Astrazeneca Ab |
Amide derivatives, process for their preparation, compositions containing them and use thereof in the manufacture of a medicament for the treatment of cytokine-mediated diseases
|
WO2000023444A1
(en)
|
1998-10-21 |
2000-04-27 |
Abbott Laboratories |
5,7-disubstituted-4-aminopyrido[2,3-d]pyrimidine compounds
|
AU769989B2
(en)
|
1998-10-23 |
2004-02-12 |
F. Hoffmann-La Roche Ag |
Bicyclic nitrogen heterocycles
|
US6358959B1
(en)
|
1999-01-26 |
2002-03-19 |
Merck & Co., Inc. |
Polyazanaphthalenone derivatives useful as alpha 1a adrenoceptor antagonists
|
AR035987A1
(es)
|
1999-03-01 |
2004-08-04 |
Smithkline Beecham Corp |
Uso de un compuesto inhibidor de la pde 4 para la manufactura de un medicamento y el medicamento para tratar asma inducida por ejercicio
|
EP1040831A3
(en)
|
1999-04-02 |
2003-05-02 |
Pfizer Products Inc. |
Use of corticotropin releasing factor (CRF) antagonists to prevent sudden death
|
WO2000066590A2
(en)
|
1999-05-04 |
2000-11-09 |
Ligand Pharmaceuticals, Inc. |
Tetracyclic progesterone receptor modulator compounds and methods
|
ATE323482T1
(de)
|
1999-07-02 |
2006-05-15 |
Stuart A Lipton |
Verwendung von p38 mapk inhibitoren in der behandlung von augenkrankheiten
|
ES2165768B1
(es)
|
1999-07-14 |
2003-04-01 |
Almirall Prodesfarma Sa |
Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
|
US6263209B1
(en)
|
1999-07-28 |
2001-07-17 |
Motorola, Inc. |
Method and apparatus in a wireless communication system for creating a learning function
|
MXPA02001830A
(es)
|
1999-08-21 |
2002-08-12 |
Byk Gulden Lomberg Chem Fab |
Combinacion sinergica de inhibidores de pde y agonista de beta 2 adrenoceptor.
|
CO5180649A1
(es)
|
1999-09-01 |
2002-07-30 |
Abbott Lab |
Antagonistas de los receptores de los glucocorticoides para el tratamiento de la diabetes para el tratamiento de la diabetes
|
ATE380814T1
(de)
|
1999-09-17 |
2007-12-15 |
Abbott Gmbh & Co Kg |
Kinaseinhibitoren als arzneimittel
|
KR20020032591A
(ko)
|
1999-09-17 |
2002-05-03 |
스튜어트 알. 수터, 스티븐 베네티아너, 피터 존 기딩스 |
라이노바이러스 감염에서의 csaid의 용도
|
OA11558A
(en)
|
1999-12-08 |
2004-06-03 |
Advanced Medicine Inc |
Beta 2-adrenergic receptor agonists.
|
AU2576501A
(en)
|
1999-12-08 |
2001-06-18 |
Advanced Medicine, Inc. |
Protein kinase inhibitors
|
US6632666B2
(en)
|
2000-01-14 |
2003-10-14 |
Biolife Solutions, Inc. |
Normothermic, hypothermic and cryopreservation maintenance and storage of cells, tissues and organs in gel-based media
|
DK1741447T3
(da)
|
2000-01-21 |
2013-12-09 |
Novartis Ag |
Kombinationer omfattende dipeptidylpeptidase-IV-inhibitorer og antidiabetiske midler
|
WO2001055147A1
(en)
|
2000-01-25 |
2001-08-02 |
Warner-Lambert Company |
PYRIDO[2,3-d]PYRIMIDINE-2,7-DIAMINE KINASE INHIBITORS
|
IL150742A0
(en)
|
2000-01-27 |
2003-02-12 |
Warner Lambert Co |
Pyridopyrimidinone derivatives for the treatment of neurodegenerative disease
|
US7235551B2
(en)
|
2000-03-02 |
2007-06-26 |
Smithkline Beecham Corporation |
1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases
|
NZ520962A
(en)
|
2000-03-06 |
2003-09-26 |
Warner Lambert Co |
5-alkylpyrido[2,3-d]pyrimidines cyclin-dependent tyrosine kinase inhibitors
|
EP1324990B1
(en)
|
2000-09-29 |
2014-10-29 |
Glaxo Group Limited |
Morpholin-acetamide derivatives for the treatment of inflammatory diseases
|
WO2002060869A2
(en)
|
2000-10-19 |
2002-08-08 |
Smithkline Beecham Corporation |
Use of p38 inhibitors for the treatment of inflammation-enhanced cough
|
NZ524806A
(en)
|
2000-10-23 |
2006-03-31 |
Smithkline Beecham Corp |
Tri-substituted 8H-pyrido[2,3-d]pyrimidin-7-one compounds
|
JP2002205986A
(ja)
|
2000-11-08 |
2002-07-23 |
Takeda Chem Ind Ltd |
ピリミジン誘導体およびそれを含有する除草剤
|
US6945422B2
(en)
*
|
2000-11-08 |
2005-09-20 |
Delphi Technologies, Inc. |
In-tank fuel line quick connector assembly
|
CA2431904A1
(en)
*
|
2000-12-20 |
2002-08-01 |
Merck & Co., Inc. |
(halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents
|
GB0031179D0
(en)
|
2000-12-21 |
2001-01-31 |
Glaxo Group Ltd |
Nitric oxide synthase inhibitors
|
US6484903B2
(en)
|
2001-01-09 |
2002-11-26 |
Riverwood International Corporation |
Carton with an improved dispensing feature in combination with a unique handle
|
GB0103630D0
(en)
|
2001-02-14 |
2001-03-28 |
Glaxo Group Ltd |
Chemical compounds
|
AU2002258400A1
(en)
|
2001-02-16 |
2002-08-28 |
Tularik Inc. |
Methods of using pyrimidine-based antiviral agents
|
DE10108481A1
(de)
|
2001-02-22 |
2002-10-24 |
Bayer Ag |
Pyridylpyrimidine
|
JP2004526720A
(ja)
|
2001-03-08 |
2004-09-02 |
グラクソ グループ リミテッド |
βアドレナリン受容体のアゴニスト
|
DE60224172T2
(de)
|
2001-03-22 |
2008-12-04 |
Glaxo Group Ltd., Greenford |
Formanilid-derivative als beta2-adrenorezeptor-agonisten
|
US7105667B2
(en)
|
2001-05-01 |
2006-09-12 |
Bristol-Myers Squibb Co. |
Fused heterocyclic compounds and use thereof
|
WO2002088079A2
(en)
|
2001-05-01 |
2002-11-07 |
Bristol-Myers Squibb Company |
Dual inhibitors of pde 7 and pde 4
|
PE20030008A1
(es)
|
2001-06-19 |
2003-01-22 |
Bristol Myers Squibb Co |
Inhibidores duales de pde 7 y pde 4
|
CA2450934A1
(en)
|
2001-06-19 |
2002-12-27 |
Marco Dodier |
Pyrimidine inhibitors of phosphodiesterase (pde) 7
|
PL211953B1
(pl)
|
2001-09-14 |
2012-07-31 |
Glaxo Group Ltd |
Pochodna fenetanoloaminy, zawierający ją środek farmaceutyczny i zastosowanie pochodnej fenetanoloaminy
|
GB0124941D0
(en)
|
2001-10-17 |
2001-12-05 |
Glaxo Group Ltd |
Chemical compounds
|
JP4178783B2
(ja)
|
2001-10-19 |
2008-11-12 |
三菱化学株式会社 |
光学記録媒体
|
US6653323B2
(en)
|
2001-11-13 |
2003-11-25 |
Theravance, Inc. |
Aryl aniline β2 adrenergic receptor agonists
|
US7019002B2
(en)
|
2001-12-11 |
2006-03-28 |
Pharmacia & Upjohn, S.P.A. |
Pyridopyrimidinones derivatives as telomerase inhibitors
|
JP2005519897A
(ja)
|
2002-01-14 |
2005-07-07 |
ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド |
グルココルチコイドミメチックス、その製造方法、それを含む医薬製剤及びその使用
|
JP4745609B2
(ja)
|
2002-01-22 |
2011-08-10 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
グルココルチコイドレセプターのための非ステロイド性リガンド、その組成物および使用
|
KR20060111716A
(ko)
|
2002-01-22 |
2006-10-27 |
워너-램버트 캄파니 엘엘씨 |
2-(피리딘-2-일아미노)-피리도[2,3-d]피리미딘-7-온
|
GB0204719D0
(en)
|
2002-02-28 |
2002-04-17 |
Glaxo Group Ltd |
Medicinal compounds
|
CN1633296A
(zh)
|
2002-03-26 |
2005-06-29 |
贝林格尔·英格海姆药物公司 |
糖皮质素模拟物、其制备方法、药物组合物及其用途
|
JP2005521717A
(ja)
|
2002-03-26 |
2005-07-21 |
ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド |
グルココルチコイドミメチックス、その製造方法、その医薬組成物、及び使用
|
DE10215316C1
(de)
|
2002-04-02 |
2003-12-18 |
Schering Ag |
Chinolin- und Isochinolin-Derivate, ein pharmazeutisches Mittel und ihre Verwendung als Entzündungshemmer
|
AU2003221706B2
(en)
|
2002-04-11 |
2008-02-28 |
Merck Sharp & Dohme Corp. |
1H-Benzo[F]indazol-5-YL derivatives as selective glucocorticoid receptor modulators
|
AU2003222841A1
(en)
|
2002-04-25 |
2003-11-10 |
Glaxo Group Limited |
Phenethanolamine derivatives
|
RU2004135392A
(ru)
*
|
2002-05-06 |
2005-06-27 |
Дженелэбс Текнолоджиз, Инк. (Us) |
Производные нуклеозидов для лечения инфекции, вызываемой вирусом гепатита с
|
ITBO20020304A1
(it)
|
2002-05-17 |
2003-11-17 |
Magneti Marelli Powertrain Spa |
Nuovi condotti in materiale polimerico
|
US7186864B2
(en)
|
2002-05-29 |
2007-03-06 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
US7074806B2
(en)
|
2002-06-06 |
2006-07-11 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
TW200409629A
(en)
*
|
2002-06-27 |
2004-06-16 |
Bristol Myers Squibb Co |
2,4-disubstituted-pyridine N-oxides useful as HIV reverse transcriptase inhibitors
|
WO2004005229A1
(en)
|
2002-07-08 |
2004-01-15 |
Pfizer Products Inc. |
Modulators of the glucocorticoid receptor
|
US6995181B2
(en)
|
2002-07-18 |
2006-02-07 |
Bristol-Myers Squibb Co. |
Modulators of the glucocorticoid receptor and method
|
DE60331103D1
(de)
|
2002-07-18 |
2010-03-11 |
Bristol Myers Squibb Co |
Zusammensetzungen und verfahren im zusammenhang mit der nuklearen hormon-rezeptor-stelle ii
|
GB0217225D0
(en)
|
2002-07-25 |
2002-09-04 |
Glaxo Group Ltd |
Medicinal compounds
|
JP2006504678A
(ja)
|
2002-08-21 |
2006-02-09 |
ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド |
グルココルチコイドミメチックス、その製造方法、その医薬組成物、及び使用
|
GB0220730D0
(en)
|
2002-09-06 |
2002-10-16 |
Glaxo Group Ltd |
Medicinal compounds
|
EP1542996A4
(en)
|
2002-09-20 |
2009-11-18 |
Merck & Co Inc |
OCTAHYDRO-2H-NAPHTOc1,2-F INDOL-4-CARBONSUUREAMIDE DERIVATIVES AS SELECTIVE MODULATORS OF THE GLUCOCORTICOID RECEPTOR
|
ES2291733T3
(es)
|
2002-10-22 |
2008-03-01 |
Glaxo Group Limited |
Compuestos de ariletanolamina medicinales.
|
GB0225030D0
(en)
|
2002-10-28 |
2002-12-04 |
Glaxo Group Ltd |
Medicinal compounds
|
NZ539676A
(en)
|
2002-10-28 |
2006-10-27 |
Glaxo Group Ltd |
Phenethanolamine derivative for the treatment of respiratory diseases
|
GB0225535D0
(en)
|
2002-11-01 |
2002-12-11 |
Glaxo Group Ltd |
Medicinal compounds
|
GB0225540D0
(en)
|
2002-11-01 |
2002-12-11 |
Glaxo Group Ltd |
Medicinal compounds
|
TW200413381A
(en)
|
2002-11-04 |
2004-08-01 |
Hoffmann La Roche |
Novel amino-substituted dihydropyrimido [4,5-d]pyrimidinone derivatives, their manufacture and use as pharmaceutical agents
|
WO2004043367A2
(en)
|
2002-11-06 |
2004-05-27 |
Bristol-Myers Squibb Company |
Fused heterocyclic compounds and use thereof
|
JP2004203751A
(ja)
|
2002-12-24 |
2004-07-22 |
Pfizer Inc |
置換6,6−ヘテロ二環式誘導体
|
EP1590341B1
(en)
|
2003-01-17 |
2009-06-17 |
Warner-Lambert Company LLC |
2-aminopyridine substituted heterocycles as inhibitors of cellular proliferation
|
MXPA05008612A
(es)
|
2003-02-14 |
2005-12-05 |
Smithkline Beecham Corp |
Compuestos novedosos.
|
US7138412B2
(en)
|
2003-03-11 |
2006-11-21 |
Bristol-Myers Squibb Company |
Tetrahydroquinoline derivatives useful as serine protease inhibitors
|
WO2004106308A1
(en)
|
2003-05-27 |
2004-12-09 |
Pfizer Products Inc. |
Quinazolines and pyrido [3,4-d] pyrimidines as receptor tyrosine kinase inhibitors
|
ATE548358T1
(de)
|
2003-08-05 |
2012-03-15 |
Vertex Pharma |
Tetrahydrochinazolin-verbindungen als inhibitoren von spannungsabhängigen ionenkanälen
|
DE102004020908A1
(de)
|
2004-04-28 |
2005-11-17 |
Grünenthal GmbH |
Substituierte 5,6,7,8,-Tetrahydro-pyrido[4,3-d]pyrimidin-2-yl- und 5,6,7,8,-Tetrahydro-chinazolin-2-yl-Verbindungen
|
US7098222B2
(en)
|
2004-05-12 |
2006-08-29 |
Abbott Laboratories |
Bicyclic-substituted amines having cyclic-substituted monocyclic substituents
|
CN101495475A
(zh)
|
2005-03-25 |
2009-07-29 |
葛兰素集团有限公司 |
制备吡啶并[2,3-d]嘧啶-7-酮和3,4-二氢嘧啶并[4,5-d]嘧啶-2(1H)-酮衍生物的方法
|
PE20061193A1
(es)
|
2005-03-25 |
2006-12-02 |
Glaxo Group Ltd |
DERIVADOS DE 3,4-DIHIDROPIRIMIDO[4,5-d]PIRIMIDIN-2-[1H]-0NA COMO INHIBIDORES DE QUINASA p38
|
US7423042B2
(en)
|
2005-03-25 |
2008-09-09 |
Glaxo Group Limited |
Compounds
|
PE20100737A1
(es)
*
|
2005-03-25 |
2010-11-27 |
Glaxo Group Ltd |
Nuevos compuestos
|
EP1885181A2
(en)
|
2005-05-23 |
2008-02-13 |
Smithkline Beecham Corporation |
Inhibition of p38 mark for treatment of obesity
|
EP1931667A1
(en)
*
|
2005-09-28 |
2008-06-18 |
Ranbaxy Laboratories Limited |
Pyrido-pyridimidine derivatives useful as antiinflammatory agents
|
EP2322523B1
(en)
*
|
2005-10-07 |
2019-01-02 |
Exelixis, Inc. |
Process for the preparation of Pyridopyrimidinone Inhibitors of PI3Kalpha
|
PE20100743A1
(es)
|
2005-11-15 |
2010-11-25 |
Glaxo Group Ltd |
Nuevos procedimientos y formulaciones
|
WO2007076085A2
(en)
*
|
2005-12-22 |
2007-07-05 |
Prolexys Pharmaceuticals, Inc . |
Fused pyrimidones and thiopyrimidones, and uses thereof
|
TW200800997A
(en)
*
|
2006-03-22 |
2008-01-01 |
Astrazeneca Ab |
Chemical compounds
|
US7723355B2
(en)
*
|
2006-11-20 |
2010-05-25 |
Bristol-Myers Squibb Company |
7,8-dihydro-1,6-naphthyridin-5(6H)-ones and related bicyclic compounds as inhibitors of dipeptidyl peptidase IV and methods
|
CA2719868A1
(en)
*
|
2008-04-29 |
2009-11-05 |
F. Hoffmann-La Roche Ag |
Pyrimidinyl pyridone inhibitors of jnk.
|